Literature DB >> 30802187

Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women's Health Initiative.

Yasmin Mossavar-Rahmani1, Victor Kamensky1, JoAnn E Manson2, Brian Silver3, Stephen R Rapp4, Bernhard Haring5, Shirley A A Beresford6, Linda Snetselaar7, Sylvia Wassertheil-Smoller1.   

Abstract

Background and Purpose- We examine the association between self-reported consumption of artificially sweetened beverages (ASB) and stroke and its subtypes, coronary heart disease, and all-cause mortality in a cohort of postmenopausal US women. Methods- The analytic cohort included 81 714 women from the Women's Health Initiative Observational Study, a multicenter longitudinal study of the health of 93 676 postmenopausal women of ages 50 to 79 years at baseline who enrolled in 1993 to 1998. This prospective study had a mean follow-up time of 11.9 years (SD of 5.3 years.) Participants who completed a follow-up visit 3 years after baseline were included in the study. Results- Most participants (64.1%) were infrequent consumers (never or <1/week) of ASB, with only 5.1% consuming ≥2 ASBs/day. In multivariate analyses, those consuming the highest level of ASB compared to never or rarely (<1/wk) had significantly greater likelihood of all end points (except hemorrhagic stroke), after controlling for multiple covariates. Adjusted models indicated that hazard ratios and 95% confidence intervals were 1.23 (1.02-1.47) for all stroke; 1.31 (1.06-1.63) for ischemic stroke; 1.29 (1.11-1.51) for coronary heart disease; and 1.16 (1.07-1.26) for all-cause mortality. In women with no prior history of cardiovascular disease or diabetes mellitus, high consumption of ASB was associated with more than a 2-fold increased risk of small artery occlusion ischemic stroke hazard ratio =2.44 (95% confidence interval, 1.47-4.04.) High consumption of ASBs was associated with significantly increased risk of ischemic stroke in women with body mass index ≥30; hazard ratio =2.03 (95% confidence interval, 1.38-2.98). Conclusions- Higher intake of ASB was associated with increased risk of stroke, particularly small artery occlusion subtype, coronary heart disease, and all-cause mortality. Although requiring replication, these new findings add to the potentially harmful association of consuming high quantities of ASB with these health outcomes.

Entities:  

Keywords:  brain ischemia; coronary heart disease; diabetes mellitus; stroke; sweetening agents

Mesh:

Substances:

Year:  2019        PMID: 30802187      PMCID: PMC6538252          DOI: 10.1161/STROKEAHA.118.023100

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

Review 1.  Non-nutritive Sweeteners and Glycaemic Control.

Authors:  Yoona Kim; Jennifer B Keogh; Peter M Clifton
Journal:  Curr Atheroscler Rep       Date:  2019-11-19       Impact factor: 5.113

2.  Association of sugar-sweetened beverage and artificially sweetened beverage intakes with mortality: an analysis of US National Health and Nutrition Examination Survey.

Authors:  Yan-Bo Zhang; Jun-Xiang Chen; Yi-Wen Jiang; Peng-Fei Xia; An Pan
Journal:  Eur J Nutr       Date:  2020-09-18       Impact factor: 5.614

3.  Response by Mossavar-Rahmani and Wassertheil-Smoller to Letters Regarding Article, "Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women's Health Initiative".

Authors:  Yasmin Mossavar-Rahmani; Sylvia Wassertheil-Smoller
Journal:  Stroke       Date:  2019-05-16       Impact factor: 7.914

4.  Association of Sugar-Sweetened Beverage Consumption with Prediabetes and Glucose Metabolism Markers in Hispanic/Latino Adults in the United States: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Jee-Young Moon; Simin Hua; Qibin Qi; Daniela Sotres-Alvarez; Josiemer Mattei; Sarah S Casagrande; Yasmin Mossavar-Rahmani; Anna María Siega-Riz; Linda C Gallo; Sylvia Wassertheil-Smoller; Robert C Kaplan; Leonor Corsino
Journal:  J Nutr       Date:  2022-01-11       Impact factor: 4.798

5.  Applying and comparing various nutrient profiling models against the packaged food supply in South Africa.

Authors:  Tamryn Frank; Shu Wen Ng; Donna R Miles; Elizabeth C Swart
Journal:  Public Health Nutr       Date:  2022-02-16       Impact factor: 4.539

Review 6.  Sucralose and Cardiometabolic Health: Current Understanding from Receptors to Clinical Investigations.

Authors:  Sydney Risdon; Sylvain Battault; Alonso Romo-Romo; Matthieu Roustit; Loic Briand; Grégory Meyer; Paloma Almeda-Valdes; Guillaume Walther
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

7.  The associations of sugar-sweetened, artificially sweetened and naturally sweet juices with all-cause mortality in 198,285 UK Biobank participants: a prospective cohort study.

Authors:  Jana J Anderson; Stuart R Gray; Paul Welsh; Daniel F Mackay; Carlos A Celis-Morales; Donald M Lyall; John Forbes; Naveed Sattar; Jason M R Gill; Jill P Pell
Journal:  BMC Med       Date:  2020-04-24       Impact factor: 8.775

8.  Moderate intake of aspartame and sucralose with meals, but not fructose, does not exacerbate energy and glucose metabolism in estrogen-deficient rats.

Authors:  Jin Ah Ryuk; Suna Kang; James W Daily; Byoung-Seob Ko; Sunmin Park
Journal:  J Clin Biochem Nutr       Date:  2019-09-11       Impact factor: 3.114

9.  Eating Behavior of Older Adults with and Without Diabetes: The Vigitel Survey, Brazil, 2016.

Authors:  Daniela de Assumpção; Ana Maria Pita Ruiz; Flavia Silva Arbex Borim; Anita Liberalesso Neri; Deborah Carvalho Malta; Priscila Maria Stolses Bergamo Francisco
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

10.  Effects of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Beverages on Cardiometabolic Risk Factors, Body Composition, and Sweet Taste Preference: A Randomized Controlled Trial.

Authors:  Cara B Ebbeling; Henry A Feldman; Sarah K Steltz; Nicolle L Quinn; Lisa M Robinson; David S Ludwig
Journal:  J Am Heart Assoc       Date:  2020-07-22       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.